Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 6, 2008, Pages 1940-1944

  Miller, Keith ^a   O'Neill, Alexander J ^a   Wilcox, Mark H ^a   Ingham, Eileen ^a   Chopra, Ian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; FUSIDIC ACID; GEMIFLOXACIN; LINEZOLID; MOXIFLOXACIN; RIBOSOME RNA; RIFAMPICIN; RNA 23S; RUFLOXACIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; GENE CONVERSION; GENE MUTATION; GENETIC RECOMBINATION; GRAM POSITIVE BACTERIUM; HOMOLOGOUS RECOMBINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RECA GENE; RNA GENE; STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FUSIDIC ACID; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; OXAZOLIDINONES; RECOMBINATION, GENETIC; RIFAMPIN; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 44449165928     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01302-07     Document Type: Article

References (33)

1. Bayles, K. W., E. W. Brunskill, J. J. Iandolo, L. L. Hruska, S. Huang, P. A. Pattee, B. K. Smiley, and R. E. Yasbin. 1994. A genetic and molecular characterization of the recA gene from Staphylococcus aureus. Gene 147:13-20.
2. BSAC. 1991. A guide to sensitivity testing; report of the working party on antibiotic sensitivity testing of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 27(Suppl. D):1-50.
3. Burman, L. G. 1977. R-plasmid transfer and its response to nalidixic acid. J. Bacteriol. 131:76-81.
4. Chambers, H. F. 1999. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J. Infect. Dis. 179:S353-S359.
5. Chopra, I., A. J. O'Neill, and K. Miller. 2003. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist. Updat. 6:137-145.
6. Cox, M. M. 2007. Regulation of bacterial RecA protein function. Crit. Rev. Biochem. Mol. Biol. 42:41-63.
7. Dutra, B. E., V. A. Sutera, Jr., and S. T. Lovett. 2007. RecA-independcnt recombination is efficient but limited by exonucleases. Proc. Natl. Acad. Sci. USA 104:216-221.
8. Fairweather, N., S. Kennedy, T. J. Foster, M. Kehoe, and G. Dougan. 1983. Expression of a cloned Staphylococcus aureus alpha-hemolysin determinant in Bacillus subtilis and Staphylococcus aureus. Infect. Immun. 41:1112-1117.
9. Falagas, M. E., I. A. Bliziotis, and K. N. Fragoulis. 2007. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am. J. Infect. Control 35:106.
10. Howden, B., and M. L. Grayson. 2006. Dumb and dumber-the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin. Infect. Dis. 42:394-400.
11. Howe, R. A., A. Noel, K. E. Bowker, V. I. Enne, T. R. Walsh, and A. P. MacGowan. 2002. Abstr. 42nd Intersci. Conf. Antimicrob. Agents Chemotherapy, abstr. CI-1608.
12. Jones, R. N., T. R. Fritsche, H. S. Sader, and J. E. Ross. 2007. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn. Microbiol. Infect. Dis. 59:309.
13. Kumari, D. N., V. Keer, P. M. Hawkey, P. Parnell, N. Joseph, J. F. Richardson, and B. Cookson. 1997. Comparison and application of ribosome spacer DNA amplicon polymorphisms and pulsed-fleld gel electrophoresis for differentiation of mcthicillin-resistant Staphylococcus aureus strains. J. Clin. Microbiol. 35:881-885.
14. Lin, W. S., T. Cunneen, and C. Y. Lee. 1994. Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus. J. Bacteriol. 176:7005-7016.
15. Lobritz, M., R. Hutton-Thomas, S. Marshall, and L. B. Rice. 2003. Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis. Antimicrob. Agents Chemother. 47:3318-3320.
16. Lujan, S. A., L. M. Guogas, H. Ragonese, S. W. Matson, and M. R. Redinbo. 2007. Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase. Proc. Natl. Acad. Sci. USA 104:12282-12287.
17. Maxwell, A. 1993. The interaction between coumarin drugs and DNA gyrasc. Mol. Microbiol. 9:681-686.
18. Meka, V. G., H. S. Gold, A. Cooke, L. Venkataraman, G. M. Eliopoulos, R. C. Moellering, Jr., and S. G. Jenkins. 2004. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus. J. Antimicrob. Chemother. 54:818-820.
19. Miller, K., A. J. O'Neill, M. H. Wilcox, E. Ingham, and I. Chopra. 2005. Development of linezolid resistance in a recA mutant of Staphylococcus aureus, abstr. C1-1413. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
20. Miller, K., A. J. O'Neill, M. H. Wilcox, E. Ingham, and I. Chopra. 2004. Suppression of linezolid resistance in Staphylococcus aureus using drug combinations, abstr. CI-1498. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
21. Muhammad, I., X. C. Li, M. R. Jacob, B. L. Tekwani, D. C. Dunbar, and D. Ferreira. 2003. Antimicrobial and antiparasitic (+)-trans-hexahydrodibenzopyrans and analogues from Machaerium multiflorum. J. Nat. Prod. 66:804-809.
22. Nathwani, D., G. D. Barlow, K. Ajdukiewicz, K. Gray, J. Morrison, B. Clift, A. J. France, and P. Davey. 2003. Cost-minimization analysis and audit of antibiotic management of bone and joint infections with ambulatory teicoplanin, in-patient care or outpatient oral linezolid therapy. J. Antimicrob. Chemother. 51:391-396.
23. Normark, B. H., and S. Normark. 2002. Evolution and spread of antibiotic resistance. J. Intern. Med. 252:91-106.
24. Palomares, J., R. Prados, and E. Perea. 1987. Effect of subinhibitory concentrations of ampicillin on the R plasmid transfer in Escherichia coli. Chemioterapia 6:256-260.
25. Pillai, S. P., C. A. Pillai, D. M. Shankel, and L. A. Mitscher. 2001. The ability of certain antimutagenic agents to prevent development of antibiotic resistance. Mutat. Res. 496:61-73.
26. Prunier, A.-L., and R. Leclercq. 2005. Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus. J. Bacteriol. 187:3455-3464.
27. Schenk, S., and R. Laddaga. 1992. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 73:133-138.
28. Schulte, B., A. Heininger, I. B. Autenrieth, and C. Wolz. 2007. Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium. Epidemiol. Infect. [Epub ahead of print.] doi: 10.1017/50950268807009508.
29. Shinabarger, D. L. 1999. Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin. Investig. Drugs 8:1195-1202.
30. Tsakris, A., S. K. Pillai, H. S. Gold, C. Thauvin-Eliopoulos, L. Venkataraman, C. Wennersten, R. C. Moellering, Jr., and G. M. Eliopoulos. 2007. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 60:649-651.
31. Tsiodras, S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, R. C. Moellering, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208.
32. Viyanen, P., and J. Boratynski. 1991. The susceptibility of conjugative resistance transfer in gram-negative bacteria to physicochemical and biochemical agents. FEMS Microbiol. Rev. 8:43-54.
33. Wooley, R., H. Dickerson, K. Simmons, E. Shotts, and J. Brown. 1986. Effect of EDTA-Tris on an Escherichia coli isolate containing R plasmids. Vet Microbiol. 12:65-75.